The Montana BioScience Alliance and industry partners are proud to announce the successful 2024 Immersion Day at Rocky Vista University and both local hospitals, the Billings Clinic and Intermountain Health, on February 23, 2024. The Immersion Day follows the Careers in Healthcare Student Summit, hosted at Montana State University Billings, on October 27, 2023.
Four Keys to Launching a Biotech Career in Montana
Students network with Montana biotech employers during the inaugural University of Montana Biotech Career Expo at Missoula College on February 15, 2024, co-hosted by the Montana High Tech Business Alliance, University of Montana College of Business, University of Montana College of Humanities and Sciences, and Missoula College.
NIH Scientists Find Weak Points on Epstein-Barr Virus
Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.
UM Integrative Physiology School opens cancer rehabilitation lab
At first glance, a room in the basement of McGill Hall on the University of Montana campus appears like a private gym with treadmills, dumbbells and exercise bikes.
It seems like a good place for a workout. But the space is actually a research laboratory for students and faculty in UM’s School of Integrative Physiology and Athletic Training within the College of Health.
Two UM researchers earn prestigious early career NSF awards
Doug Brinkerhoff intends to use computer deep learning to improve predictions of sea level rise from melting ice sheets. Beverly Piggott will study how brain cells regulate their own acidity during development.
Montana State scientists publish novel research on how individual cells respond to viral infection
A team of scientists from Montana State University recently published unique research examining how individual cells respond to viral infection. The work used state-of-the-art technology to culture cells and track infection in real time; it is the first known project to use microfluidic technology to culture, infect and track infection on a single-cell level.
Montana State researcher wins prestigious NIH grant to study osteoarthritis
A Montana State University researcher was recently awarded a $2.76 million, five-year grant from the National Institutes of Health to help find pre-symptom evidence of the onset of osteoarthritis, a disease that affects one in seven Americans.
Wintermute Biomedical Secures $1.3M USD Funding and Commences ZOSTER EASE Phase Ib Clinical Trial for Solexan™ in Shingles Treatment
Wintermute Biomedical has successfully raised USD 1.3 million from investors to propel its groundbreaking Shingles treatment, Solexan™, into a Phase Ib clinical trial. The primary focus of this randomized double-blind placebo-controlled trial is to assess the safety, tolerability, and proof-of-concept efficacy of Solexan™ in reducing shingles-related pain and expediting lesion healing.
Golden Helix Received ISO 13485:2016 Certification
Golden Helix, Inc. announced that it has received the certification for ISO 13485:2016 from TÜV SÜD. ISO 13485:2016 is an international standard that specifies requirements for a quality management system (QMS) for organizations involved in the design, development, production, and servicing of medical devices.